Drug application
GRISACTIN (GRISEOFULVIN, MICROCRYSTALLINE)
Drugs@FDA ANDA 060212 · WYETH AYERST
Key facts
| Drug name | GRISACTIN |
|---|---|
| Active ingredients | GRISEOFULVIN, MICROCRYSTALLINE |
| Application type | ANDA |
| Application number | 060212 |
| Company | WYETH AYERST |
| Dosage forms | TABLET, ORAL |
| Strength | 500MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jun 20, 1972 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: